Children and adolescents experience unique long COVID symptoms

A study characterizes childhood long COVID, revealing distinct symptoms in children and adolescents, highlighting the need for tailored diagnostic approaches.

European Commission to work more closely with European Medicines Agency

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible

November 7, 2024

AstraZeneca’s rare blood disorder pill approved in Japan

AstraZeneca’s add-on pill for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) won its first approval in Japan, the company announced Friday. The drug, an

January 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.